Skip to main content
. Author manuscript; available in PMC: 2009 Jan 5.
Published in final edited form as: Mol Cancer Ther. 2007 Nov 7;6(11):2879–2890. doi: 10.1158/1535-7163.MCT-07-0297

Figure 5. P450 2B11 RNA and protein levels during the course of metronomic CPA treatment.

Figure 5

A. qPCR assay revealed that P450 2B11 RNA levels were unchanged in the first two cycles of CPA treatment. B. Anti-P450 2B11 Western blot of microsomal protein extracts prepared from frozen tumor samples after 0–12 days of metronomic CPA treatment. Expression of P450 2B11 protein decreased following the second CPA injection. By day 12, tumor samples showed little or no detectable P450 2B11 protein (last 3 lanes on right).